WuXi Biologics has over 5,600 employees, including more than 450 scientists with advanced degrees and rich work experience in antibody development, manufacturing, quality control, preclinical research and registration. Our senior management team members have worked at the forefront of the biologics industry over the last 20 years, enabling us to create a world-class pharmaceutical biologics discovery, development and manufacturing team.
JiJie Gu, Ph.D.
Chief Scientific Officer, Executive Vice President
20+ years’ experience in biologics R&D
AbbVie, Abbott, Harvard University
Editorial board, mAbs and Antibody Therapeutics
Peking Union Medical College (Ph.D.)
Harvard Medical School & Harvard School of Public Health (Postdoctoral Fellow)
George R. Skillin, MBA
Vice President, Global Engineering
30+ years’ experience in corporate engineering, production management and management consulting
Pfizer, Wyeth, Merck, Ernst & Young Life Sciences
Member – Board of Directors of the Boston Chapter of ISPE
University of Rochester (MBA), University of Maine (B.S. ChE)